IL1F10
Interleukin-1 family member 10
Also known as: FKSG75, IL-1F10, IL-1HY2, IL1-theta, IL1FA_HUMAN, MGC11983, MGC119832, MGC119833
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8WWZ1
- Gene
- IL1F10
- Ensembl
- ENSG00000136697
- Chromosome
- 2
- Canonical length
- 152 aa
- Protein class
- Predicted intracellular proteins, Predicted secreted proteins
- Secretome location
- Secreted to blood
OverviewNCBI Gene
The protein encoded by this gene is a member of the interleukin 1 cytokine family. This gene and eight other interleukin 1 family genes form a cytokine gene cluster on chromosome 2. This cytokine is thought to participate in a network of interleukin 1 family members to regulate adapted and innate immune responses. Two alternatively spliced transcript variants encoding the same protein have been reported. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
152 residues, UniProt reviewed canonical sequence.
>Q8WWZ1|IL1F10
1 MCSLPMARYY IIKYADQKAL YTRDGQLLVG DPVADNCCAE KICILPNRGL ARTKVPIFLG
61 IQGGSRCLAC VETEEGPSLQ LEDVNIEELY KGGEEATRFT FFQSSSGSAF RLEAAAWPGW
121 FLCGPAEPQQ PVQLTKESEP SARTKFYFEQ SWLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL1F10 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- skin: 12 nTPM
- tonsil: 2.6 nTPM
- breast: 0.4 nTPM
- cervix: 0.1 nTPM
- esophagus: 0.1 nTPM
- thymus: 0.1 nTPM
Single-cell type
- esophageal apical cells: 2.4 nCPM
- ocular epithelial cells: 0.5 nCPM
- early spermatids: 0.4 nCPM
- esophageal suprabasal cells: 0.3 nCPM
- mesothelial cells: 0.3 nCPM
- migrating cytotrophoblasts: 0.3 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- amygdala: 0 nTPM
- basal ganglia: 0 nTPM
- cerebellum: 0 nTPM
- cerebral cortex: 0 nTPM
- choroid plexus: 0 nTPM
- hippocampal formation: 0 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.85
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.28
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to lipopolysaccharide
- cytokine-mediated signaling pathway
- immune response
- inflammatory response
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL1F10 as an antibody target. Whether an autoantibody or antibody against IL1F10 could matter depends on whether native IL1F10 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL1F10 is annotated as secreted, so native IL1F10 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label IL1F10 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...